Avoiding the risk of missed symptoms in patients with asymptomatic aortic stenosis (AS)

The importance of timely referral

Timely and prompt identification of symptoms in patients with sAS is critical for avoiding sudden death and ensuring they receive the treatment they need.1,2,8

 

However, up to 50% of patients with sAS report no symptoms at the time of diagnosis and more than 80% are unable to identify the key symptoms, which can make detecting their onset and the optimal timing for intervention a challenge. Correctly identifying symptom onset can be difficult for a number of reasons, including:1,2,4

 

  • A sedentary lifestyle due to the older age of patients and lockdowns during COVID-19
  • Symptoms being attributed to other conditions or masked by a sedentary lifestyle due to the older age of patients
  • The variable and unpredictable nature of AS

Watch Professor Bernard Prendergast discuss the importance of correctly identifying patients with asymptomatic sAS, as well as the different diagnostic and treatment options available.

Play Video

Professor Bernard Prendergast

6 min

Undetected symptoms can put patients’ lives at increased risk1,2,7

Despite a lack of symptoms, patients with asymptomatic sAS may still need urgent treatment. Symptom-free survival at 12 months was 49% for patients with limiting symptoms on exercise testing and 89% for those without.7

 

The consequences of late diagnosis of symptoms by not stress testing asymptomatic patients can be serious. In a prospective study of patients with supposed asymptomatic sAS:1

  • There was an 81% probability of patients experiencing an event (mortality or the development of symptoms)
  • 6% experienced sudden death

Especially when patients do display symptoms the urgency to treat remains, as — if left untreated — the risk of death increases three-fold within the first 6 months.3

Event-free survival in patients with asymptomatic sAS according to exercise testing1

Using a stress test to expose symptoms in asymptomatic patients

One way to effectively detect if a patient’s condition is worsening and requires urgent treatment is with a stress test. Yet, studies show that stress tests were given in less than 5% of asymptomatic patients with AS.10

 

The ESC/EACTS guidelines recommend that stress testing is performed as part of the 6-monthly assessments in patients with asymptomatic sAS.11 Stress testing can be performed with exercise or by pharmacological means depending on the patient’s ability.4

Exercise testing is considered the optimal method for assessing patients who are able to exercise and has been shown to be safe for patients with asymptomatic sAS:4
Running
Exercise testing can be conducted either by treadmill or bicycle.
bicycle
Running
bicycle
Exercise testing can be conducted either by treadmill or bicycle.
Heart
Pharmacological testing provides an alternative mode of stress testing in the ~15% of patients with symptomatic sAS who cannot exercise. For these patients, the administration of dobutamine can be used to mimic the effect of exercise on the heart.4

Check our latest articles

Tavi podcast series
Podcast Episode 4 – Benchmarking Efficiencies, Pre, Peri and Post TAVI Procedure
Jul 2021 Read more
How can TAVI benefit your low-risk patients with severe aortic stenosis (sAS) now and in the future?
Jul 2021 Read more

Stay informed with our newsletter

Our monthly updates provide you the latest developments in TAVI and aortic stenosis.     Read more

References

  • 1Amato MCM, et al. Heart 2001;86(4):381—386.
  • 2Généreux P, et al. J Am Coll Cardiol. 2016;67(19):2263—2288.
  • 3Malaisrie SC, et al. Ann Thorac Surg. 2014;98:1564—1571.
  • 4Redfors B, et al. Circulation. 2017;135(20):1956—1976.
  • 5Ammar A, et al. Nutrients. 2020;12(6):1583.
  • 6Shah RB, et al. Catheter Cardiovasc Interv. 2020;96(3):659—663.
  • 7Das P et al. Eur Heart J. 2005;26(13):1309—1313.
  • 8Brown ML, et al. J Thorac Cardiovasc Surg. 2008;135(2):308—315.
  • 9Thoenes M, et al. J Thorac Dis. 2018; 10(9): 5584—5594.
  • 10Iung B, et al. Circulation 2019;140(14):1156—1169.
  • 11Baumgartner H, et al. Eur Heart J. 2017;38(36):2739—2791.

Content relating to Tavi.today is intended for healthcare professionals. Click OK to confirm you are a healthcare professional and proceed.

Skip to content